Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

February 15, 2022; Volume 19,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. An, Na

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

B

  1. Bi, Jinghao

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634

C

  1. Cao, Lei

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  2. Chen, Yiyu

    1. You have access
      The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752

D

  1. Davidson, Nancy E.

    1. You have access
      Updates in endocrine therapy for metastatic breast cancer
      Poorni M. Manohar and Nancy E. Davidson
      Cancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255
  2. Ding, Kefeng

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  3. Ding, Yuwei

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  4. Dong, Jilin

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  5. Du, Guanhua

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651

F

  1. Fu, Dongliang

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  2. Fu, Fenfen

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  3. Fu, Shuna

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  4. Fu, Weiqi

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651

G

  1. Ge, Jingyu

    1. You have access
      The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
  2. Guo, Yuchen

    1. You have access
      A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
      Yuchen Guo, Yangyang Zhou and Wenxin Qin
      Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520

H

  1. Hao, Qian

    1. You have access
      The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
      Qian Hao and Xiang Zhou
      Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
  2. He, Jinjie

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  3. Hou, Chunyu

    1. You have access
      Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
      Xiaodong Zhang, Chunyu Hou and Guang Yang
      Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
  4. Hu, Li

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  5. Hu, Yeting

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532

J

  1. Ji, Xiaowei

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  2. Jiang, Yufei

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634

K

  1. Kong, Xiangxing

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532

L

  1. Le, Baoyu

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  2. Lei, Qunying

    1. You have access
      Cancer metabolism and dietary interventions
      Lin Qian, Fan Zhang, Miao Yin and Qunying Lei
      Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
  3. Li, Honglan

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  4. Li, Sha

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  5. Li, Wan

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  6. Li, Wei

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  7. Li, Zhuoying

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  8. Lian, Xiaohua

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  9. Liu, Bing

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  10. Liu, Jinyi

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  11. Liu, Xiangrui

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  12. Lu, Yinying

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

M

  1. Manohar, Poorni M.

    1. You have access
      Updates in endocrine therapy for metastatic breast cancer
      Poorni M. Manohar and Nancy E. Davidson
      Cancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255

Q

  1. Qian, Lin

    1. You have access
      Cancer metabolism and dietary interventions
      Lin Qian, Fan Zhang, Miao Yin and Qunying Lei
      Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
  2. Qin, Wenxin

    1. You have access
      A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
      Yuchen Guo, Yangyang Zhou and Wenxin Qin
      Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520

R

  1. Ren, Liwen

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651

S

  1. Shao, Zhiming

    1. You have access
      The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
  2. Shen, Qiuming

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  3. Sundaram, Senthil

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358

T

  1. Tan, Yinuo

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  2. Tang, Yang

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  3. Tao, Minzhen

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  4. Teng, Fei

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  5. Tuo, Jiayi

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634

W

  1. Wang, Jinhua

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  2. Wang, Juan

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  3. Wu, Qiong

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

X

  1. Xiang, Yongbing

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  2. Xiao, Qian

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  3. Xie, Yuntao

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  4. Xie, Zhen

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  5. Xu, Dong

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  6. Xu, Libin

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  7. Xu, Yajie

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  8. Xu, Ye

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358

Y

  1. Yang, Baoxing

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  2. Yang, Guang

    1. You have access
      Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
      Xiaodong Zhang, Chunyu Hou and Guang Yang
      Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
  3. Yang, Mengyuan

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  4. Yang, Yihui

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  5. Yao, Lu

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  6. Yin, Miao

    1. You have access
      Cancer metabolism and dietary interventions
      Lin Qian, Fan Zhang, Miao Yin and Qunying Lei
      Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
  7. Ying, Dingge

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  8. Yu, Keda

    1. You have access
      The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
  9. Yu, Yu

    1. You have access
      Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  10. Yuan, Huiyun

    1. You have access
      Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  11. Yuan, Ying

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
    2. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213

Z

  1. Zhang, Dongjie

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  2. Zhang, Fan

    1. You have access
      Cancer metabolism and dietary interventions
      Lin Qian, Fan Zhang, Miao Yin and Qunying Lei
      Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
  3. Zhang, Haochen

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  4. Zhang, Juan

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  5. Zhang, Xiaodong

    1. You have access
      Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
      Xiaodong Zhang, Chunyu Hou and Guang Yang
      Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
  6. Zhang, Ying

    1. You have access
      Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
      Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
      Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
  7. Zhao, Yingxin

    1. You have access
      Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
  8. Zheng, Xiangjin

    1. You have access
      Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  9. Zhou, Xiang

    1. You have access
      The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
      Qian Hao and Xiang Zhou
      Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
  10. Zhou, Xinyi

    1. You have access
      Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  11. Zhou, Yangyang

    1. You have access
      A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
      Yuchen Guo, Yangyang Zhou and Wenxin Qin
      Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
  12. Zuo, Wenjia

    1. You have access
      The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (2)
Cancer Biology & Medicine
Vol. 19, Issue 2
15 Feb 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire